Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free CCAP Stock Alerts

Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC logo
$11.33 -0.31 (-2.66%)
As of 11:20 AM Eastern
Compare
Annual Income Statements for Crescent Capital BDC

Annual Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 84 -43 0.26 -16
Consolidated Net Income / (Loss)		 79 -43 0.26 -16
Net Income / (Loss) Continuing Operations		 79 -43 0.26 -16
Total Pre-Tax Income 		79 -43 0.26 -16
Total Revenue		 83 0.00 0.00 0.00
Net Interest Income / (Expense)		 83 0.00 0.00 0.00
Total Interest Income		 83 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00
Total Non-Interest Income		 0.79 0.00 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments		 - 0.00 0.00 0.00
Total Non-Interest Expense		 4.40 0.00 0.00 0.00
Nonoperating Income / (Expense), net		 - -43 0.26 -16
Basic Earnings per Share		 $1.67 $1.93 $2.30 $2.40
Weighted Average Basic Shares Outstanding		 28.48M 30.89M 35.93M 37.06M
Diluted Earnings per Share		 $1.67 $1.93 $2.30 $2.40
Weighted Average Diluted Shares Outstanding		 28.48M 30.89M 35.93M 37.06M
Weighted Average Basic & Diluted Shares Outstanding		 - 30.89M 37.06M 37.06M

Quarterly Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Consolidated Net Income / (Loss)		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Net Income / (Loss) Continuing Operations		 -18 -23 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Pre-Tax Income 		-18 -22 -9.93 1.41 0.98 7.80 4.35 -1.50 -1.77 -17
Total Revenue		 0.00 -19 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Total Non-Interest Income		 0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Net Realized & Unrealized Capital Gains on Investments		 0.00 -25 0.00 0.00 0.00 - 0.00 0.00 6.44 -6.44
Nonoperating Income / (Expense), net		 -18 - -9.93 1.41 0.98 7.80 4.35 -1.50 -8.22 -10
Basic Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Basic Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Diluted Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Weighted Average Diluted Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Weighted Average Basic & Diluted Shares Outstanding		 30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M

Annual Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 8.68 -6.46 7.40 15
Net Cash From Operating Activities		 -158 28 92 59
Net Cash From Continuing Operating Activities		 -158 28 92 59
Net Income / (Loss) Continuing Operations		 84 16 84 74
Consolidated Net Income / (Loss)		 84 16 84 74
Amortization Expense		 -8.73 -5.12 -5.17 -6.46
Non-Cash Adjustments to Reconcile Net Income		 -227 8.55 13 -10
Changes in Operating Assets and Liabilities, net		 -5.35 8.97 0.66 2.04
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 166 -34 -85 -43
Net Cash From Continuing Financing Activities		 166 -34 -85 -43
Issuance of Debt		 790 339 548 347
Issuance of Common Equity		 53 0.00 0.00 0.00
Repayment of Debt		 -629 -318 -565 -312
Repurchase of Common Equity		 -0.52 0.00 0.00 0.00
Payment of Dividends		 -48 -55 -65 -75
Other Financing Activities, Net		 0.54 -0.22 -3.86 -3.43
Effect of Exchange Rate Changes		 0.01 -0.01 0.09 -0.49
Cash Interest Paid		 15 27 55 60
Cash Income Taxes Paid		 2.18 1.97 0.67 1.34

Quarterly Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 2.60 -4.39 17 -13 1.29 1.72 7.48 4.19 1.70 1.59
Net Cash From Operating Activities		 -18 42 16 20 21 35 39 -25 47 -2.89
Net Cash From Continuing Operating Activities		 -17 41 16 20 21 35 39 -25 47 -2.89
Net Income / (Loss) Continuing Operations		 -2.38 2.60 7.78 23 23 31 28 20 15 9.99
Consolidated Net Income / (Loss)		 -2.38 2.60 7.78 23 23 31 28 20 15 9.99
Amortization Expense		 -0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Non-Cash Adjustments to Reconcile Net Income		 -13 38 20 -12 15 -9.29 21 -44 26 -14
Changes in Operating Assets and Liabilities, net		 -1.04 1.29 -9.91 11 -15 15 -7.36 0.04 7.28 2.07
Net Cash From Financing Activities		 21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Net Cash From Continuing Financing Activities		 21 -47 1.40 -33 -20 -33 -32 29 -45 4.97
Issuance of Debt		 98 62 156 46 233 113 60 125 55 107
Repayment of Debt		 -62 -97 -138 -64 -235 -127 -73 -75 -82 -83
Payment of Dividends		 -14 -13 -13 -15 -18 -19 -19 -19 -19 -18
Other Financing Activities, Net		 - - -3.63 - -0.23 0.01 0.00 -1.90 - -1.53
Effect of Exchange Rate Changes		 -0.01 -0.01 0.00 0.02 -0.03 0.10 -0.07 0.06 0.02 -0.49
Cash Interest Paid		 9.16 7.13 15 12 17 12 18 13 17 13
Cash Income Taxes Paid		 - - 0.53 - - 0.14 1.26 - - 0.08

Annual Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 2,515 1,303 1,627 1,656
Cash and Due from Banks		 - 6.40 7.78 10
Restricted Cash		 - 11 17 29
Trading Account Securities		 - 8.15 1,587 4.82
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00
Other Assets		 2,515 1,268 1.46 1,600
Total Liabilities & Shareholders' Equity		 0.00 1,303 1,627 1,656
Total Liabilities		 0.00 690 885 916
Other Short-Term Payables		 - 5.86 3.45 3.71
Long-Term Debt		 0.00 654 845 876
Other Long-Term Liabilities		 0.00 18 21 21
Commitments & Contingencies		 - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.00 613 743 741
Total Preferred & Common Equity		 0.00 613 743 741
Preferred Stock		 - 0.00 0.00 0.00
Total Common Equity		 0.00 613 743 741
Common Stock		 - 675 966 959
Retained Earnings		 - -62 -223 -218

Quarterly Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 1,339 1,631 1,625 1,624 1,620 1,672 1,645
Cash and Due from Banks		 13 21 7.54 6.00 6.74 11 17
Restricted Cash		 9.41 13 14 17 25 25 21
Trading Account Securities		 - 7.51 7.07 8.85 4.71 2.77 1.40
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets		 1,317 23 1,584 28 21 23 1,595
Total Liabilities & Shareholders' Equity		 1,339 1,631 1,625 1,624 1,620 1,672 1,645
Total Liabilities		 717 913 899 894 869 920 896
Other Short-Term Payables		 - - 3.24 - - - 3.76
Long-Term Debt		 691 883 859 864 840 891 857
Other Long-Term Liabilities		 25 30 23 30 29 29 21
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 623 718 726 730 752 752 749
Total Preferred & Common Equity		 623 718 726 730 752 752 749
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 623 718 726 730 752 752 749
Common Stock		 666 788 788 788 966 966 966
Retained Earnings		 -44 -70 -63 -58 -214 -213 -217

Annual Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - -
Revenue Growth		 638.18% -100.00% 0.00% 0.00%
EBITDA Growth		 396.17% -107.29% -1.04% -25.05%
EBIT Growth		 496.17% -100.00% 0.00% 0.00%
NOPAT Growth		 -21.30% -100.00% 0.00% 0.00%
Net Income Growth		 44.39% -154.95% 100.61% -6,125.86%
EPS Growth		 -7.22% 15.57% 19.17% 4.35%
Operating Cash Flow Growth		 -155.11% 117.73% 230.21% -36.18%
Free Cash Flow Firm Growth		 0.00% 151.23% -125.67% 90.92%
Invested Capital Growth		 0.00% -49.63% 25.29% 1.83%
Revenue Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
EBITDA Q/Q Growth		 0.00% 0.00% 93.35% -157.96%
EBIT Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
NOPAT Q/Q Growth		 0.00% 0.00% 100.00% -100.00%
Net Income Q/Q Growth		 0.00% 0.00% 100.36% -278.49%
EPS Q/Q Growth		 0.00% 0.00% 4.07% -2.83%
Operating Cash Flow Q/Q Growth		 0.00% 121.89% -7.28% -38.89%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 98.18%
Invested Capital Q/Q Growth		 0.00% 0.00% 6,612,903.38% 0.65%
Profitability Metrics		 - - - -
EBITDA Margin		 84.25% 0.00% 0.00% 0.00%
EBIT Margin		 94.72% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 94.72% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 0.00% 0.00% 0.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.28% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.28% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -14.16% 0.04% -2.14%
Cash Return on Invested Capital (CROIC)		 -193.72% 66.00% -22.45% -1.82%
Operating Return on Assets (OROA)		 3.14% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 3.14% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -14.16% 0.04% -2.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -7.08% 0.04% -2.14%
Net Operating Profit after Tax (NOPAT)		 79 0.00 0.00 0.00
NOPAT Margin		 94.72% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 2.74% -0.04% 1.84%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 5.28% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 79 0.00 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 70 -5.12 -5.17 -6.46
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.51 0.78 0.96
Price to Tangible Book Value (P/TBV)		 0.00 0.51 0.78 0.96
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 2,192.89 0.00
Dividend Yield		 13.51% 17.55% 11.63% 10.61%
Earnings Yield		 0.00% 0.00% 0.05% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.75 0.88 0.96
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 34.07 15.14 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.76 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 1.07 1.14 1.18
Long-Term Debt to Equity		 0.00 1.07 1.14 1.18
Financial Leverage		 0.00 5.17 1.11 1.16
Leverage Ratio		 0.00 6.23 2.16 2.21
Compound Leverage Factor		 0.00 0.00 0.00 0.00
Debt to Total Capital		 0.00% 51.65% 53.22% 54.18%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 51.65% 53.22% 54.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 48.35% 46.78% 45.82%
Debt to EBITDA		 0.00 -127.92 -163.43 -135.49
Net Debt to EBITDA		 0.00 -124.59 -158.70 -129.40
Long-Term Debt to EBITDA		 0.00 -127.92 -163.43 -135.49
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 -2,436 1,248 -320 -29
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.03 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 2,515 1,267 1,587 1,616
Invested Capital Turnover		 0.07 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 2,515 -1,248 320 29
Enterprise Value (EV)		 0.00 952 1,397 1,549
Market Capitalization		 0.00 315 577 712
Book Value per Share		 $0.00 $19.83 $20.04 $19.98
Tangible Book Value per Share		 $0.00 $19.83 $20.04 $19.98
Total Capital		 0.00 1,267 1,587 1,616
Total Debt		 0.00 654 845 876
Total Long-Term Debt		 0.00 654 845 876
Net Debt		 0.00 637 820 836
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 43 -0.26 16
Net Nonoperating Obligations (NNO)		 2,515 654 845 876
Total Depreciation and Amortization (D&A)		 -8.73 -5.12 -5.17 -6.46
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Basic Shares Outstanding		 0.00 30.89M 35.93M 37.06M
Adjusted Diluted Earnings per Share		 $0.00 $1.93 $2.30 $2.40
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 30.89M 35.93M 37.06M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 30.89M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)		 55 0.00 0.00 0.00
Normalized NOPAT Margin		 66.31% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 94.72% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 60.46% -127.45% 24,543.73% -474.73%
Augmented Payout Ratio		 61.12% -127.45% 24,543.73% -474.73%

Quarterly Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -100.00% 0.00% -100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 62.29% 0.00% -102.58% 96.05% 93.69% 88.31% -29.19% -93.38% 477.70% -340.34%
EBIT Growth		 100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth		 100.00% 0.00% -100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 -544.73% 0.00% -118.15% 107.82% 105.27% 133.41% 143.81% -206.09% -281.85% -316.93%
EPS Growth		 15.56% 0.00% 38.46% 12.00% 13.46% 17.31% 16.67% 5.36% 8.47% -11.48%
Operating Cash Flow Growth		 0.00% 136.78% 43.35% 390.57% 218.22% -17.31% 146.74% -221.14% 119.82% -108.35%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 100.19% 0.00% -5,489,327.66% -23,525,510.03% -6,671,974.99% 89.51%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 25.29% 5,489,227.66% 23,525,610.03% 6,690,663.48% 1.83%
Revenue Q/Q Growth		 100.00% 0.00% 100.00% -100.00% -100.00% 0.00% -100.00% 0.00% 529.82% -200.00%
EBITDA Q/Q Growth		 95.61% -1,591.69% 97.90% 92.92% -300.00% -43.79% -129.59% -160.48% 251.67% -267.64%
EBIT Q/Q Growth		 100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
NOPAT Q/Q Growth		 100.00% 0.00% 100.00% 100.00% -100.00% 0.00% -100.00% -100.00% 529.82% -200.00%
Net Income Q/Q Growth		 1.94% -31.72% 84.68% -97.81% -31.00% 700.21% -44.26% 0.00% -18.28% -854.60%
EPS Q/Q Growth		 4.00% 0.00% 3.85% 3.70% 5.36% 3.39% 3.28% 0.00% 8.47% -15.63%
Operating Cash Flow Q/Q Growth		 -158.07% 331.68% -61.75% 27.05% 4.99% 62.06% 14.14% 0.00% 290.52% -106.16%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 99.90% -98.00% -1,334,760.86% -20,467.03% -39,312.72% -144,797.96% 97.90%
Invested Capital Q/Q Growth		 0.00% 0.00% -462.51% 124.09% -111.43% 6,612,903.38% 26,530,182.33% 1,273,864.77% 603,676.02% 0.65%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 71.75% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Tax Burden Percent		 100.00% 108.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 0.00% 152.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 262.69%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.58% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.13% 0.00%
Return on Equity (ROE)		 0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Cash Return on Invested Capital (CROIC)		 0.00% 98.52% 0.00% 0.00% 0.00% -22.45% -99.09% 1.41% -99.45% -1.82%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.20% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.60% 0.00%
Return on Common Equity (ROCE)		 0.00% -14.16% 0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 1.70% -2.14%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.93% 1.55% 1.19% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 1.26% -68,461.49% -40,454.40% 8,123.44% -1.04% -1.04% 0.34% 1.47% 1.44%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 0.00 -14 0.00 0.00 0.00 0.00 0.00 0.00 6.44 -6.44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.89 -15 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 4.62 -7.75
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Tangible Book Value (P/TBV)		 0.00 0.51 0.00 0.00 0.00 0.78 0.78 0.00 0.89 0.96
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 2,242.77 0.00 37.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 2,192.89 40.57 0.00 75.30 0.00
Dividend Yield		 15.86% 17.55% 15.54% 13.20% 11.56% 11.63% 12.00% 11.39% 11.36% 10.61%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 2.46% 0.00% 1.33% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.75 0.00 67,909.39 0.00 0.88 0.88 0.00 0.93 0.96
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 133.41 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 5,315.82 0.00 82.34 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 96.16 0.00 167.58 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 34.07 10.54 7.89 5.54 15.14 12.07 0.00 15.44 26.29
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Long-Term Debt to Equity		 0.00 1.07 0.00 0.00 0.00 1.14 1.12 1.18 1.14 1.18
Financial Leverage		 0.00 1.07 0.00 0.00 0.00 1.11 1.12 1.18 1.14 1.16
Leverage Ratio		 0.00 6.23 0.00 0.00 0.00 2.16 2.16 2.22 2.20 2.21
Compound Leverage Factor		 0.00 9.52 0.00 0.00 0.00 0.00 0.00 0.00 -0.60 5.82
Debt to Total Capital		 0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 51.65% 100.00% 100.00% 100.00% 53.22% 52.78% 54.21% 53.38% 54.18%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 48.35% 0.00% 0.00% 0.00% 46.78% 47.22% 45.79% 46.62% 45.82%
Debt to EBITDA		 0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Net Debt to EBITDA		 0.00 -124.59 0.00 0.00 0.00 -158.70 -152.21 161.11 73.47 -129.40
Long-Term Debt to EBITDA		 0.00 -127.92 0.00 0.00 0.00 -163.43 -158.22 167.92 76.86 -135.49
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 55.59 73.52 92.29 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 57.79 76.63 96.55 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.03 -0.01 0.02 -320 -1,592 -1,643 -1,602 -34
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 1,267 -0.03 0.01 -0.02 1,587 1,592 1,643 1,606 1,616
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00
Increase / (Decrease) in Invested Capital		 0.00 0.00 -0.03 0.01 -0.02 320 1,592 1,643 1,606 29
Enterprise Value (EV)		 0.00 952 346 474 551 1,397 1,398 0.00 1,488 1,549
Market Capitalization		 0.00 315 346 474 551 577 590 0.00 669 712
Book Value per Share		 $0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Tangible Book Value per Share		 $0.00 $19.83 $0.00 $0.00 $0.00 $20.04 $20.28 $20.30 $20.20 $19.98
Total Capital		 0.00 1,267 -0.12 -0.06 -0.06 1,587 1,592 1,643 1,606 1,616
Total Debt		 0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Total Long-Term Debt		 0.00 654 -0.12 -0.06 -0.06 845 840 891 857 876
Net Debt		 0.00 637 -0.12 -0.06 -0.06 820 808 855 819 836
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 18 8.28 9.93 -1.41 -0.98 -7.80 -4.35 1.50 6.28 12
Net Nonoperating Obligations (NNO)		 0.00 654 -0.03 0.01 -0.02 845 840 891 857 876
Total Depreciation and Amortization (D&A)		 -0.89 -0.95 -1.38 -0.80 -1.22 -1.76 -1.79 -1.55 -1.82 -1.31
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Basic Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Diluted Earnings per Share		 $0.52 $0.52 $0.54 $0.56 $0.59 $0.61 $0.63 $0.59 $0.64 $0.54
Adjusted Weighted Average Diluted Shares Outstanding		 30.89M 30.89M 32.47M 37.06M 37.06M 35.93M 37.06M 37.06M 37.06M 37.06M
Adjusted Basic & Diluted Earnings per Share		 ($0.08) $0.00 $0.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.89M 30.89M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M
Normalized Net Operating Profit after Tax (NOPAT)		 0.00 -15 0.00 0.00 0.00 0.00 0.00 0.00 4.51 -4.51
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 70.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -27.52% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%
Augmented Payout Ratio		 0.00% -127.45% -48.29% -315.91% -81.14% 24,543.73% 486.88% 643.88% 851.51% -474.73%

Financials Breakdown Chart

Key Financial Trends

Crescent Capital BDC (NASDAQ: CCAP) showed a weaker finish to 2024, with profitability swinging sharply lower in Q4 after a solid first half of the year. The company remained profitable for the full year on a quarterly basis, but the latest numbers point to pressure from investment marks and a heavier dependence on leverage and dividends to support cash flow.

  • Q4 2024 generated $9.99 million of net income, reversing the prior quarter’s loss and showing the business can still produce earnings.
  • For Q4 2024, financing activity remained positive overall, with $4.97 million of net cash from financing activities after debt issuance, repayments, and dividends.
  • The company continued paying a dividend, which may appeal to income-focused investors, with $18.16 million paid in Q4 2024.
  • Cash and equivalents improved from $6.74 million at Q1 2024 to $17.09 million at Q3 2024, helping liquidity during the year.
  • Total equity edged higher over 2024, rising from $751.7 million at Q1 2024 to $748.8 million at Q3 2024, despite market volatility.
  • Quarterly earnings were relatively volatile in 2024, ranging from $28.0 million in Q1 to a $16.9 million loss in Q4, suggesting results are highly sensitive to portfolio marks and financing costs.
  • Weighted average shares stayed flat at 37.1 million in 2024, indicating no major dilution in the latest reported quarters.
  • Long-term debt remained substantial, at about $857.2 million in Q3 2024 versus $840.2 million in Q1 2024, so leverage remains a key feature of the balance sheet.
  • Cash interest paid remained elevated, including $12.7 million in Q4 2024 and $16.9 million in Q3 2024, reflecting meaningful borrowing costs.
  • Q4 2024 posted a $16.9 million net loss attributable to common shareholders, compared with a $1.8 million loss in Q3 2024 and $4.35 million profit in Q1 2024.
  • Revenue in Q4 2024 was negative $6.4 million, driven by a $6.44 million loss on realized and unrealized capital gains, which is a sharp deterioration from prior quarters.
  • Operating cash flow turned negative in Q4 2024 at negative $2.89 million, down from $46.9 million in Q3 2024 and $39.5 million in Q1 2024.
  • The company relied on debt issuance to fund activities, including $107.5 million of debt issued in Q4 2024, while still repaying $82.8 million, underscoring ongoing refinancing needs.
  • Retained earnings remained negative at negative $217.1 million in Q3 2024, showing the company has a long history of cumulative losses despite recent profitability.

Bottom line: CCAP still has the profile of a cash-generating business that supports dividends, but the latest quarter was weak and highlighted the risk of valuation-driven earnings swings. Investors should watch whether the company can stabilize investment income and operating cash flow while managing its leverage and dividend coverage.

06/03/26 11:47 AM ETAI Generated. May Contain Errors.

Crescent Capital BDC Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Crescent Capital BDC's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Crescent Capital BDC's net income appears to be on a downward trend, with a most recent value of -$15.85 million in 2024, falling from $78.94 million in 2021. The previous period was $263 thousand in 2023. See where experts think Crescent Capital BDC is headed by visiting Crescent Capital BDC's forecast page.

Over the last 3 years, Crescent Capital BDC's total revenue changed from $83.34 million in 2021 to $0.00 in 2024, a change of -100.0%.

Crescent Capital BDC's total liabilities were at $915.64 million at the end of 2024, a 3.5% increase from 2023, and a 91,563,700,000.0% increase since 2021.

In the past 3 years, Crescent Capital BDC's cash and equivalents has ranged from $0.00 in 2021 to $10.13 million in 2024, and is currently $10.13 million as of their latest financial filing in 2024.

Over the last 3 years, Crescent Capital BDC's book value per share changed from 0.00 in 2021 to 19.98 in 2024, a change of 1,998.4%.


Related Companies

Financial statements for NASDAQ:CCAP last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel